Dube Michael P 4
4 · Intellia Therapeutics, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Dube Michael P
VP, Chief Accounting Officer
Transactions
- Award
Common Stock
2025-03-01+14,000→ 59,640 total
Footnotes (1)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.